JP2018024670A5 - - Google Patents

Download PDF

Info

Publication number
JP2018024670A5
JP2018024670A5 JP2017154317A JP2017154317A JP2018024670A5 JP 2018024670 A5 JP2018024670 A5 JP 2018024670A5 JP 2017154317 A JP2017154317 A JP 2017154317A JP 2017154317 A JP2017154317 A JP 2017154317A JP 2018024670 A5 JP2018024670 A5 JP 2018024670A5
Authority
JP
Japan
Prior art keywords
compound
following formula
salt
formula
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017154317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018024670A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018024670A publication Critical patent/JP2018024670A/ja
Publication of JP2018024670A5 publication Critical patent/JP2018024670A5/ja
Withdrawn legal-status Critical Current

Links

JP2017154317A 2006-11-15 2017-08-09 キナーゼ活性の阻害剤 Withdrawn JP2018024670A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2006906359 2006-11-15
AU2006906359A AU2006906359A0 (en) 2006-11-15 Inhibitors of kinase activity
US90151207P 2007-02-14 2007-02-14
US60/901,512 2007-02-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015190233A Division JP2016041697A (ja) 2006-11-15 2015-09-28 キナーゼ活性の阻害剤

Publications (2)

Publication Number Publication Date
JP2018024670A JP2018024670A (ja) 2018-02-15
JP2018024670A5 true JP2018024670A5 (sv) 2018-04-19

Family

ID=39401255

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2009536562A Active JP5461189B2 (ja) 2006-11-15 2007-11-15 キナーゼ活性の阻害剤
JP2013229858A Withdrawn JP2014065713A (ja) 2006-11-15 2013-11-05 キナーゼ活性の阻害剤
JP2015078465A Active JP6444800B2 (ja) 2006-11-15 2015-04-07 キナーゼ活性の阻害剤
JP2015190233A Withdrawn JP2016041697A (ja) 2006-11-15 2015-09-28 キナーゼ活性の阻害剤
JP2017154317A Withdrawn JP2018024670A (ja) 2006-11-15 2017-08-09 キナーゼ活性の阻害剤

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2009536562A Active JP5461189B2 (ja) 2006-11-15 2007-11-15 キナーゼ活性の阻害剤
JP2013229858A Withdrawn JP2014065713A (ja) 2006-11-15 2013-11-05 キナーゼ活性の阻害剤
JP2015078465A Active JP6444800B2 (ja) 2006-11-15 2015-04-07 キナーゼ活性の阻害剤
JP2015190233A Withdrawn JP2016041697A (ja) 2006-11-15 2015-09-28 キナーゼ活性の阻害剤

Country Status (15)

Country Link
US (2) US8461161B2 (sv)
EP (3) EP2848610B1 (sv)
JP (5) JP5461189B2 (sv)
AU (1) AU2007321719B2 (sv)
CA (1) CA2701959C (sv)
CY (1) CY1119528T1 (sv)
DK (1) DK2848610T3 (sv)
ES (1) ES2645947T3 (sv)
HK (2) HK1207637A1 (sv)
HU (1) HUE035868T2 (sv)
LT (1) LT2848610T (sv)
PL (1) PL2848610T3 (sv)
PT (1) PT2848610T (sv)
SI (1) SI2848610T1 (sv)
WO (1) WO2008058341A1 (sv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
AU2007321719B2 (en) 2006-11-15 2013-11-21 Ym Biosciences Australia Pty Ltd Inhibitors of kinase activity
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
BRPI0814423B1 (pt) * 2007-07-17 2022-04-19 Plexxikon, Inc Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
TW200920369A (en) 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
US8436171B2 (en) * 2008-02-01 2013-05-07 Akinion Pharmaceuticals Ab Amino substituted pyrazines as inhibitors or protein kinases
KR20160129109A (ko) 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
BRPI0923401B1 (pt) * 2008-12-24 2021-11-23 Syngenta Limited Método para o preparo de aril amidas e composto
AR078033A1 (es) 2009-04-03 2011-10-12 Plexxikon Inc Una dispersion solida, que contiene al compuesto {3-[5-(4-(cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico, composiciones y formulaciones que comprenden a dicha dispersion solida; metodos para fabricar dicha dispersion solida, formas 1 y 2 de
US9115404B2 (en) 2009-06-19 2015-08-25 Max-Delbrück-Centrum Für Molekulare Medizin Berlin-Buch Polynucleotides for medical use
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
CN102712646A (zh) * 2009-08-28 2012-10-03 阵列生物制药公司 Raf抑制剂化合物及其使用方法
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
RU2549546C2 (ru) * 2009-12-22 2015-04-27 Мерк Шарп и Доум Б.В. Аминогетероарильные производные в качестве блокаторов hcn
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
KR102132405B1 (ko) 2010-05-20 2020-07-09 어레이 바이오파마 인크. Trk 키나제 저해제로서의 매크로시클릭 화합물
MA34948B1 (fr) 2011-02-07 2014-03-01 Plexxikon Inc Composes et procedes de modulation de kinase, et leurs indications
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
US9408952B2 (en) * 2011-11-30 2016-08-09 Abbott Cardiovascular Systems Inc. Pediatric application of bioabsorbable polymer stents in infants and children with congenital heart defects
US8748097B1 (en) * 2011-12-02 2014-06-10 President And Fellows Of Harvard College Identification of agents for treating calcium disorders and uses thereof
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
GB201211310D0 (en) * 2012-06-26 2012-08-08 Chroma Therapeutics Ltd CSF-1R kinase inhibitors
CA2897538A1 (en) * 2013-01-10 2014-07-17 Pulmokine, Inc. Therapeutic indications of kinase inhibitors
AU2014205483B2 (en) * 2013-01-10 2017-11-30 Gilead Sciences, Inc. Non-selective kinase inhibitors
MA38394B1 (fr) 2013-03-15 2018-04-30 Glaxosmithkline Ip Dev Ltd Dérivés pyridine utilisés comme inhibiteurs de la kinase réarrangée au cours de la transfection (ret)
TW201524958A (zh) 2013-03-15 2015-07-01 Glaxosmithkline Ip Dev Ltd 用作轉染期間重排抑制劑之新穎化合物
CN103214413B (zh) * 2013-03-22 2015-05-13 郑州泰基鸿诺药物科技有限公司 一种含杂环的三氟甲基酮化合物及其制备方法
CN111743901B (zh) 2013-10-11 2023-09-12 普尔莫凯恩股份有限公司 喷雾干燥制剂
AU2014338070A1 (en) * 2013-10-23 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Quinazolinone and isoquinolinone derivative
MX2017002610A (es) 2014-08-29 2017-10-11 Tes Pharma S R L INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA.
AU2015316438B2 (en) 2014-09-10 2018-05-24 Glaxosmithkline Intellectual Property Development Limited Novel compounds as Rearranged during Transfection (RET) inhibitors
PE20170705A1 (es) 2014-09-10 2017-05-21 Glaxosmithkline Ip Dev Ltd Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion)
CN104628659A (zh) * 2015-01-27 2015-05-20 广西师范大学 具有抗肿瘤作用的吡嗪-芳基脲衍生物及其制备方法与应用
LT3322706T (lt) 2015-07-16 2021-03-10 Array Biopharma, Inc. Pakeistieji pirazolo[1,5-a]piridino junginiai, kaip ret kinazės inhibitoriai
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
KR102543227B1 (ko) 2016-10-27 2023-06-13 풀모킨 인코포레이티드 폐고혈압을 치료하기 위한 병용 요법
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
CA3049136C (en) 2017-01-18 2022-06-14 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
TWI676482B (zh) * 2017-03-23 2019-11-11 高雄醫學大學 盤基蛋白結構域受體1的抑制劑及活化劑及其用途
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
TW202410896A (zh) 2017-10-10 2024-03-16 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
JP6997876B2 (ja) 2018-01-18 2022-02-04 アレイ バイオファーマ インコーポレイテッド Retキナーゼ阻害剤としての置換ピラゾリル[4,3-c]ピリジン化合物
US11524963B2 (en) 2018-01-18 2022-12-13 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
JP7060694B2 (ja) 2018-01-18 2022-04-26 アレイ バイオファーマ インコーポレイテッド Retキナーゼ阻害剤としての置換ピロロ[2,3-d]ピリミジン化合物
JP2019138438A (ja) 2018-02-15 2019-08-22 日本精工株式会社 スピンドル装置
US11964988B2 (en) 2018-09-10 2024-04-23 Array Biopharma Inc. Fused heterocyclic compounds as RET kinase inhibitors
KR102329723B1 (ko) * 2019-08-30 2021-11-23 한국과학기술연구원 단백질 키나아제 저해 활성을 갖는 신규한 피리미도[4,5-d]피리미딘-2-온 유도체
KR102329720B1 (ko) 2019-08-30 2021-11-23 한국과학기술연구원 단백질 키나아제 저해 활성을 갖는 신규한 피리미도[4,5-d]피리미딘-2-온 유도체
WO2021239643A1 (en) * 2020-05-25 2021-12-02 Chiesi Farmaceutici S.P.A. Benzylamine derivatives as ddrs inhibitors
WO2022159745A1 (en) * 2021-01-22 2022-07-28 Hibercell, Inc. Gcn2 modulating compounds and uses thereof
EP4334300A1 (en) 2021-05-07 2024-03-13 GB005, Inc. Crystalline forms of n-{3-[(1s)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methods

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5488231A (en) * 1977-12-22 1979-07-13 Sumitomo Chem Co Ltd 3-phenyloxymethylaniline derivative, its preparation, and herbicides consisting of it
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
JPH10513442A (ja) 1995-02-02 1998-12-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5−htレセプターアンタゴニストとしてのインドール誘導体
AU6526896A (en) * 1995-07-22 1997-02-18 Rhone-Poulenc Rorer Limited Substituted aromatic compounds and their pharmaceutical use
US6001879A (en) 1995-08-30 1999-12-14 Bayer Aktiengesellschaft Acylaminosalicylic acid amides and their uses as pesticides
JPH09268169A (ja) * 1996-04-01 1997-10-14 Otsuka Chem Co Ltd サリチル酸アニリド誘導体、それを有効成分として含む植物病害防除剤
ES2223091T3 (es) 1997-04-04 2005-02-16 Aventis Pharma Deutschland Gmbh Derivados de propanolamina hipolipidemicos.
AUPO863197A0 (en) * 1997-08-18 1997-09-11 Fujisawa Pharmaceutical Co., Ltd. Novel derivatives
US6143780A (en) * 1999-09-17 2000-11-07 Uniroyal Chemical Company, Inc. N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV
US6479552B2 (en) * 1999-09-23 2002-11-12 G.D. Searle & Co. Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
US6825198B2 (en) 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
US7253190B2 (en) * 2001-10-04 2007-08-07 Merck & Co., Inc. Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5
CA2486183C (en) 2002-05-23 2012-01-10 Cytopia Pty Ltd. Protein kinase inhibitors
AUPS251502A0 (en) * 2002-05-23 2002-06-13 Cytopia Pty Ltd Protein kinase inhibitors
DE60331187D1 (de) 2002-05-23 2010-03-25 Cytopia Res Pty Ltd Kinaseinhibitoren
EP1522314B1 (en) 2002-06-26 2014-03-05 Ono Pharmaceutical Co., Ltd. Remedies for diseases caused by vascular contraction or dilation
EP1545523A1 (en) 2002-07-03 2005-06-29 Astex Technology Limited 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
AU2003251944B2 (en) * 2002-07-15 2008-06-26 Myriad Genetics, Inc. Compounds, compositions, and methods employing same
AU2002953255A0 (en) 2002-12-11 2003-01-02 Cytopia Research Pty Ltd Protein kinase inhibitors
KR20050106421A (ko) * 2003-02-07 2005-11-09 오노 야꾸힝 고교 가부시키가이샤 카르복실산 화합물
WO2005002673A1 (en) 2003-07-03 2005-01-13 Astex Therapeutics Limited Raf kinase inhibitors
ATE455546T1 (de) * 2003-08-06 2010-02-15 Vertex Pharma Aminotriazol-verbindungen als proteinkinase- hemmer
WO2005040152A1 (en) * 2003-10-20 2005-05-06 E.I. Dupont De Nemours And Company Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides
BRPI0417354A (pt) * 2003-12-03 2007-03-13 Cytopia Res Pty Ltd compostos inibidores de tubulina, composições e seus usos
ZA200602666B (en) * 2004-01-12 2007-09-26 Cytopia Res Pty Ltd Selective kinase inhibitors
EP1789393A2 (en) * 2004-07-30 2007-05-30 GPC Biotech AG Pyridinylamines
JP2006111553A (ja) * 2004-10-13 2006-04-27 Dainippon Sumitomo Pharma Co Ltd スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
WO2006065204A1 (en) * 2004-12-14 2006-06-22 Astrazeneca Ab Substituted aminopyridines and uses thereof
AU2006203828B2 (en) * 2005-01-07 2009-12-03 Emory University CXCR4 antagonists for the treatment of medical disorders
ES2684821T3 (es) * 2005-12-29 2018-10-04 Lexicon Pharmaceuticals, Inc. Derivados de aminoácidos multicíclicos y métodos de su uso
US20070208053A1 (en) 2006-01-19 2007-09-06 Arnold Lee D Fused heterobicyclic kinase inhibitors
AU2007321719B2 (en) 2006-11-15 2013-11-21 Ym Biosciences Australia Pty Ltd Inhibitors of kinase activity

Similar Documents

Publication Publication Date Title
JP2018024670A5 (sv)
JP2017008120A5 (sv)
JP2019194236A5 (sv)
JP2018168171A5 (sv)
JP2020515557A5 (sv)
JP2017186358A5 (sv)
JP2018521020A5 (sv)
JP2016153424A5 (sv)
JP2021020948A5 (sv)
JP2019089762A5 (sv)
JP2018150298A5 (sv)
JP2017222697A5 (sv)
JP2020534795A5 (sv)
JP2018024682A5 (sv)
JP2021502388A5 (sv)
JP2018536572A5 (sv)
JP2015199738A5 (sv)
JP2012111758A5 (sv)
JP2010501534A5 (sv)
JP2009535462A5 (sv)
EP4335439A3 (en) Compounds
JP2018116258A5 (sv)
JP2017506627A5 (sv)
JP2015522045A5 (sv)
JP2021502386A5 (sv)